💨 Abstract
Sana Biotechnology Inc. reported a second-quarter loss of $93.8 million, equivalent to 39 cents per share. When adjusted for non-recurring costs, the loss was 16 cents per share, beating analysts' expectations of a 20 cents per share loss. The Seattle-based company's results surpassed Wall Street forecasts.
Courtesy: WTOP Staff
Suggested
Inflation likely moved higher last month as tariffs bite, putting the Fed in bind -
Federal becomes local: The nation’s capital finds itself at the center of a Donald Trump maelstrom -
Brewers claim 10th straight game and become 1st team since 2019 with 2 double-digit win streaks -
Trump’s Washington police takeover echoes history of racist narratives about urban crime -
Bolivia’s election may spell the end of its long-ruling left. Here’s what to know -
FIFA moves ahead with new human rights strategy for World Cup games, but advocates are skeptical -
Sports Betting Line -
Astros hold off Red Sox rally for 7-6 win, Urías and McCormick homer -
Photos of mourning for Colombian Sen. Miguel Uribe, who died 2 months after shooting at a rally -
Spencer Torkelson’s tiebreaking homer in the 9th gives the Tigers a 2-1 victory over the White Sox -